A detailed history of Srs Capital Advisors, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 2,000 shares of PACB stock, worth $3,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 1,000 100.0%
Holding current value
$3,140
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.2 - $2.17 $1,200 - $2,170
1,000 Added 100.0%
2,000 $3,000
Q4 2023

Feb 06, 2024

BUY
$5.97 - $10.36 $2,985 - $5,180
500 Added 100.0%
1,000 $9,000
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $4,115 - $6,965
500 New
500 $4,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $353M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.